The mortality rate for genitourinary system diseases in Sweden is forecasted to gradually increase from 1.61 thousand deaths in 2024 to 1.7 thousand deaths in 2028. This reflects a year-on-year growth of approximately 1.24% from 2024 to 2025, 1.23% from 2025 to 2026, 1.85% from 2026 to 2027, and 1.19% from 2027 to 2028. Comparing data from 2022 and 2023, the rate saw an average annual increase of around 2.64%. The Compound Annual Growth Rate (CAGR) for the forecasted period 2024-2028 stands at around 1.32% per year.
Future trends to watch for include advancements in medical technology, changes in healthcare policies, and lifestyle changes among the Swedish population. These factors could alter the mortality rates associated with genitourinary diseases, potentially improving patient outcomes and decreasing mortality rates over time.
